Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Early on-demand drinking to relieve thirst after urological endoscopy

Official title: Effectiveness of Early Oral Hydration in Relieving Postoperative Thirst in Patients Undergoing Urological Endoscopic Procedures: A Randomized Controlled Trial

Run by Sindh Institute of Urology and Transplantation · NCT07563530 · Data updated 2026-11-12

This test sees if allowing adults to drink on demand in the recovery room reduces thirst and improves satisfaction after elective urological endoscopic procedures.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment200 (estimated)
SponsorSindh Institute of Urology and Transplantation
Academic / other
Locations1 site (Karachi, Sindh)
StatusRecruiting
StartedApril 18, 2026
Main results expectedOctober 18, 2026
Study endsOctober 18, 2026
Registry record updatedMay 4, 2026
Trial IDNCT07563530 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 undergoing elective, day-case urological endoscopic procedures under general anesthesia who are ASA I–III and can swallow and communicate are ideal candidates.

Probably not a fit

Patients with gastrointestinal disorders that contraindicate early drinking, swallowing dysfunction, inability to communicate, requirement for nasogastric suction, incomplete reversal of anesthesia, or those outside the 18–65 age range may not receive benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Postoperative thirst is a common discomfort after urological endoscopic procedures but oral intake is often delayed due to concerns about nausea and aspiration. In this interventional trial, participants are randomized to early on-demand oral hydration in the postanesthesia care unit (PACU) versus standard delayed hydration per PACU protocol. Eligible patients are adults 18–65 scheduled for elective day-case urological endoscopy under general anesthesia (ASA I–III), with exclusions for gastrointestinal contraindications, swallowing dysfunction, inability to communicate, need for nasogastric suction, recent facial/oropharyngeal surgery, or incomplete reversal of muscle relaxants. Primary outcomes include patient-reported thirst relief and satisfaction, with monitoring for nausea, vomiting, aspiration, and other adverse events.

Why it matters

Potential benefit: If successful, patients could get faster relief from thirst and a more comfortable recovery without added complications.

How similar studies have gone: Previous small trials in ambulatory surgery have shown early oral hydration can safely reduce thirst and improve satisfaction, though data specific to urological endoscopy remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Male and female patients aged 18-65 years.
2. Scheduled for elective urological endoscopic procedures under general anesthesia.
3. Day-care endoscopic procedures.
4. ASA classification I-III.

Exclusion Criteria:

1. Known gastrointestinal disorders contraindicating early oral hydration (e.g., peptic ulcer disease, hiatal hernia, irritable bowel syndrome, esophagitis, or prior gastrointestinal surgery).
2. Inability to express thirst or communicate (e.g., language barrier, altered consciousness).
3. Requirement for nasogastric suction.
4. History of facial, oropharyngeal, or laryngeal surgery.
5. Swallowing dysfunction or delayed gastric emptying (e.g., gastroparesis).
6. Incomplete reversal of muscle relaxant at PACU admission (no adequate spontaneous breathing or protective airway reflexes).

Where it's running

  • Sindh Institute of Urology and Transplantation
    Karachi, Sindh, Pakistan
    Recruiting

Study contacts

  • Principal investigator: Muhammad M Abbas, FCPS — Sindh Institute of Urology and Transplantation
  • Study coordinator: Muhammad M Abbas, FCPS
  • Email: smabbas69@hotmail.com
  • Phone: 02199215718

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.